Leveraging synthetic biology and novel materials, xBiologix uses their cutting-edge technology to create innovative infectious disease diagnostics. Their current focus is on developing non-invasive COVID-19 diagnostics that empower individuals, businesses, and communities to quickly, accurately, and inexpensively determine their COVID-19 health status. By detecting even a few virus particles in asymptomatic individuals or before symptoms appear, xBiologix is actively contributing to getting the world back to normal.

Their synthetic biology platform enables them to reduce background noise, increase binding capacity, and significantly lower the limit of detection. This allows for the detection of pathogens at the onset of the disease, even before symptoms develop. xBiologix's first diagnostic products are highly accurate, single-use, non-invasive COVID-19 antigen tests that provide results within minutes.

They are also working on another groundbreaking development—a non-invasive, in-home test for Flu-A, Flu-B, and COVID-19. To learn more about their products or participate in their trials, interested individuals can contact xBiologix via email at sales@xbiologix. com.

They are committed to making proteins work and revolutionizing the field of diagnostics